NCT00660309View on ClinicalTrials.gov

A Clinical Study to Evaluate Renal Hemodynamic Responses to Aliskiren in Patients With Type 2 Diabetes Mellitus

PHASE4CompletedINTERVENTIONAL

Enrollment

45

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

Aliskiren

Aliskiren 300 mg tablets

DRUG

Irbesartan

Irbesartan 300 mg tablets

DRUG

Captopril

Captopril 25 mg tablet

Trial Locations (1)

02115

Novartis Investigator Site, Boston

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY